Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Triple Negative Breast Cancer|Camrelizumab
Interventions: DRUG: （Carrelizumab + TCb） regimen|DRUG: TCb regimen
Sponsor: Zhenzhen Liu